Axa S.A. Opko Health, Inc. Transaction History

Axa S.A.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$1.5 - $2.17 $39,750 - $57,505	-26,500 Reduced 2.32%	1,115,300 $1.78 Million
Q2 2023 Aug 14, 2023	BUY	$1.37 - $2.17 $1.52 Million - $2.41 Million	1,109,600 Added 3445.96%	1,141,800 $2.48 Million
Q4 2022 Feb 14, 2023	SELL	$1.05 - $2.01 $241,211 - $461,747	-229,725 Reduced 87.71%	32,200 $40,000
Q3 2022 Feb 14, 2023	BUY	$1.81 - $2.81 $25,159 - $39,059	13,900 Added 5.6%	261,925 $495,000
Q3 2022 Nov 14, 2022	BUY	$1.81 - $2.81 $25,159 - $39,059	13,900 Added 5.6%	261,925 $495,000
Q2 2022 Feb 14, 2023	SELL	$2.33 - $3.61 $438,214 - $678,950	-188,075 Reduced 43.13%	248,025 $627,000
Q2 2022 Aug 15, 2022	SELL	$2.33 - $3.61 $438,214 - $678,950	-188,075 Reduced 43.13%	248,025 $627,000
Q1 2022 Feb 14, 2023	BUY	$2.87 - $4.93 $499,882 - $858,682	174,175 Added 66.5%	436,100 $1.5 Million
Q1 2022 May 13, 2022	BUY	$2.87 - $4.93 $1.17 Million - $2.01 Million	407,100 Added 1403.79%	436,100 $1.5 Million
Q4 2021 Feb 14, 2022	BUY	$3.52 - $5.15 $102,080 - $149,350	29,000 New	29,000 $139,000

255

187M

6.03M

10.1M

Ticker OPK
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 771,960,000
Market Cap $1.19B
Description
OPKO Health, Inc., a healthcare company, engages in the diagnostics and pharmaceuticals businesses in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. The company's Diagnostics segment operates BioReference Laboratories that offers laboratory testing services for the detection, diagnosis, evaluation, monitoring, and...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.